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Abstract 
 
The aim of this study was to identify and characterise peptidyl-prolyl cis-trans 
isomerases (PPIases) from the bacterium Burkholderia pseudomallei, the causative 
agent of the disease melioidosis. The longer term goal was to assess their potential 
as vaccine candidates or antimicrobial targets. 
 
Using bioinformatic approaches, six putative FK506-binding proteins (FKBPs) 
proteins and three putative parvulin proteins were identified in B. pseudomallei. Of 
these, six were expressed and purified as recombinant proteins. The purified 
proteins were used to immunise BALB/c mice, with some providing protection 
against a subsequent B. pseudomallei infection. These proteins could therefore be 
proposed as potential vaccine candidates. 
 
Homologues of Mip or SurA, which are associated with virulence in other bacterial 
species, were identified in B. pseudomallei and closely related B. thailandensis. 
Recombinant Mip or SurA homologues from B. pseudomallei were shown to have 
characteristic PPIase enzyme activity. To evaluate the role of the Mip homologue 
from B. pseudomallei in virulence, an unmarked deletion mutant was constructed. 
The mutant had reduced intracellular survival; defects in putative virulence 
mechanisms and attenuated virulence in mice. To assess the role of a SurA 
homologue, closely related B. thailandensis was used as a model organism, with 
deletion of the gene resulting in defects in intracellular infection, outer membrane 
integrity and virulence. This indicates that PPIases from B. pseudomallei and B. 
thailandensis represent novel virulence determinants and potential antimicrobial 
targets for therapeutics against melioidosis.  
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